Peripheral Interventions Market
PUBLISHED: 2024 ID: SMRC24786
SHARE
SHARE

Peripheral Interventions Market

Peripheral Interventions Market Forecasts to 2030 - Global Analysis By Product (Catheters, Sheath, Guide Wires, Atherectomy Devices, Embolic Devices, Stents, Inferior Vena Cava (IVC) Thrombectomy Devices, Plaque Modification Device, Hemodynamic Flow Alteration Devices and Other Products), Procedures (Oncology Procedures, Gastric, Neurology, Skin Procedures, Uteral, Renal, Hepatic and Other Procedures), Application, End User and By Geography

4.1 (100 reviews)
4.1 (100 reviews)
Published: 2024 ID: SMRC24786

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $8,952.2 MN

Projected Year Value (2030)

US $17,668.5 MN

CAGR (2023 - 2030)

10.2%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Peripheral Interventions Market is accounted for $8,952.2 million in 2023 and is expected to reach $17,668.5 million by 2030 growing at a CAGR of 10.2% during the forecast period. The term ""peripheral interventions"" describes medical procedures used to treat diseases affecting the arteries and veins that are not part of the heart or brain, or the peripheral vascular system. Medical professionals utilize various minimally invasive techniques during peripheral interventions, such as angioplasty, stent placement, atherectomy, and thrombectomy. Therefore, these procedures often provide effective alternatives to traditional open surgeries, offering quicker recovery times and reduced risks.

According to the American Heart Association, a patient in Canada spends around USD 4,600 per year on treatment and diagnosis of peripheral atrial disease.

Market Dynamics: 

Driver: 

Growing healthcare expenditure

The availability of cutting-edge tools enhances the precision and efficacy of these procedures, attracting healthcare professionals and fostering patient confidence in these advanced treatment options. Increasing financial investments in healthcare witnessed globally and particularly in developed economies, plays a crucial role in advancing medical technologies and treatment modalities. In addition, this financial support facilitates research and development, leading to continuous innovation in peripheral interventions, which is driving this market size.

Restraint:

High cost

Medical equipment and devices used in peripheral interventions can have high costs because of their expensive manufacturing, research and development in compliance with regulations. Using cutting-edge imaging techniques like intravascular ultrasound and angiography also contributes to the high price. Furthermore, this market size is being hampered by the cost of the knowledge and training needed to carry out peripheral interventions.

Opportunity:

Favorable reimbursement policies

Reimbursement structures that adequately cover the costs associated with peripheral interventions incentivize healthcare providers to offer these advanced procedures, ensuring accessibility for patients. Industry stakeholders, including manufacturers and developers of peripheral intervention technologies, also benefit from favorable reimbursement policies. Furthermore, when reimbursement aligns with the value of these interventions, it encourages healthcare facilities to invest in state-of-the-art technologies and skilled personnel, ultimately promoting the adoption of peripheral interventions and significantly propelling market growth.

Threat:

Lack of awareness and education

Physicians and healthcare providers may not be fully aware of the latest advancements, which results in a lack of awareness and underutilization of peripheral interventions as a treatment option. Limited patient education and awareness campaigns contribute to the under-recognition of symptoms, delayed diagnosis, and subsequent treatment. In addition, this lack of knowledge may lead patients to opt for traditional treatment methods or remain untreated altogether, making it complex and hampering market growth.

Covid-19 Impact

The COVID-19 pandemic has had a notable negative impact on the peripheral intervention market. The restrictions imposed to curb the spread of the virus, such as lockdowns and limitations on elective procedures, led to a significant decline in the number of non-urgent peripheral interventions. Fear of contracting the virus in hospital settings caused patients to postpone or cancel procedures, which reduced the demand for peripheral intervention services and devices. Moreover, disruptions in the global supply chain and manufacturing processes hampered market expansion.

The atherectomy devices segment is expected to be the largest during the forecast period

The atherectomy devices segment is estimated to hold the largest share due to the fact that it involves the removal of atherosclerotic plaque from blood vessels, facilitates improved blood flow, and reduces the risk of complications such as ischemia and limb-threatening conditions. It utilizes various techniques, including rotational, orbital, laser, and directional atherectomy. Additionally, their effectiveness in treating complex arterial lesions while offering advantages such as reduced trauma to the vessel walls and enhanced outcomes compared to traditional methods driving this segment's growth.

The venous thromboembolism segment is expected to have the highest CAGR during the forecast period

The venous thromboembolism segment is anticipated to have lucrative growth during the forecast period due to its ability to address medical procedures and interventions aimed at managing conditions involving blood clots within the veins. These interventions are crucial for preventing the progression of thrombotic events, reducing the risk of complications, and improving overall patient outcomes. Furthermore, mechanical thrombectomy devices may be employed to physically remove the clot, enhancing the efficacy of clot removal while minimizing invasiveness, which is boosting segment expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to a robust landscape characterized by technological advancements, high healthcare expenditure, and a growing prevalence of peripheral vascular diseases. Collaborations between healthcare providers, industry stakeholders, and research institutions ensure a continuous influx of novel technologies and treatment modalities. Furthermore, favorable reimbursement policies and a proactive regulatory environment contribute to the rapid adoption of advanced peripheral intervention procedures, which are driving this region’s growth.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period due to a rising prevalence of peripheral vascular diseases. Countries like China, Japan, India, and Australia are witnessing a surge in demand for advanced interventional procedures due to factors such as aging populations, lifestyle changes, and heightened awareness of minimally invasive treatment options. Additionally, peripheral interventions, including angioplasty, stenting, atherectomy, and thrombectomy, are gaining traction as viable alternatives to traditional surgical approaches, which are boosting this region’s expansion.  

Key players in the market

Some of the key players in the Peripheral Interventions Market include Boston Scientific Corporation, Abbott Laboratories, W. L. Gore & Associates Inc, AngioDynamics Inc., Medtronic, Teleflex Incorporated, Cardinal Health Inc, Terumo Corporation, Biotronik SE & Co. KG, C.R. Bard Inc., Cook Medical, Terumo Interventional Systems Inc, Becton Dickinson and Company, B. Braun Melsungen AG and St. Jude Medical.

Key Developments:

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

In November 2023, Terumo announced the launch of Insulin Syringe, Sterile delivery device for patients requiring regular insulin injections, thereby raising the bar for patient comfort and therapy compliance.

In June 2023, the American Diabetes Association® (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.

In June 2023, Terumo Aortic announced the launch of the company’s global Post-Approval Study (PAS) known as EXTEND for Thoraflex Hybrid, the only Frozen Elephant Trunk (FET) device approved by the US Food and Drug Administration (FDA) for the treatment of patients with complex aortic arch disease.

Products Covered:
• Catheters
• Sheath
• Guide Wires
• Atherectomy Devices
• Embolic Devices
• Stents
• Inferior Vena Cava (IVC)
• Thrombectomy Devices
• Plaque Modification Device
• Hemodynamic Flow Alteration Devices
• Other Products

Procedures Covered:
• Oncology Procedures 
• Gastric 
• Neurology 
• Skin Procedures 
• Uteral 
• Renal 
• Hepatic 
• Other Procedures 

Applications Covered:
• Venous Thromboembolism
• Peripheral Artery Disease
• Other Applications

End Users Covered:
• Hospitals
• Ambulatory Surgical Centers
• Catheterization Laboratories
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary           
            
2 Preface           
 2.1 Abstract          
 2.2 Stake Holders          
 2.3 Research Scope          
 2.4 Research Methodology          
  2.4.1 Data Mining         
  2.4.2 Data Analysis         
  2.4.3 Data Validation         
  2.4.4 Research Approach         
 2.5 Research Sources          
  2.5.1 Primary Research Sources         
  2.5.2 Secondary Research Sources         
  2.5.3 Assumptions         
            
3 Market Trend Analysis           
 3.1 Introduction          
 3.2 Drivers          
 3.3 Restraints          
 3.4 Opportunities          
 3.5 Threats          
 3.6 Product Analysis          
 3.6 Application Analysis          
 3.7 End User Analysis          
 3.8 Emerging Markets          
 3.10 Impact of Covid-18          
            
4 Porters Five Force Analysis           
 4.1 Bargaining power of suppliers          
 4.2 Bargaining power of buyers          
 4.3 Threat of substitutes          
 4.4 Threat of new entrants          
 4.5 Competitive rivalry          
            
5 Global Peripheral Interventions Market, By Product           
 5.1 Introduction          
 5.2 Catheters          
 5.3 Sheath          
 5.4 Guide Wires          
 5.5 Atherectomy Devices          
 5.6 Embolic Devices          
 5.7 Stents          
  5.7.1 Bare Metal Stents         
  5.7.2 Drug-Eluting Stents         
 5.8 Inferior Vena Cava (IVC)          
 5.9 Thrombectomy Devices          
 5.10 Plaque Modification Device          
 5.11 Hemodynamic Flow Alteration Devices          
 5.12 Other Products          
            
6 Global Peripheral Interventions Market, By Procedures           
 6.1 Introduction          
 6.2 Oncology Procedures          
 6.3 Gastric          
 6.4 Neurology          
 6.5 Skin Procedures          
 6.6 Uteral          
 6.6 Renal          
 6.7 Hepatic          
 6.8 Other Procedures          
            
7 Global Peripheral Interventions Market, By Application           
 7.1 Introduction          
 7.2 Venous Thromboembolism          
 7.3 Peripheral Artery Disease          
 7.4 Other Applications          
            
8 Global Peripheral Interventions Market, By End User           
 8.1 Introduction          
 8.2 Hospitals          
 8.3 Ambulatory Surgical Centers          
 8.4 Catheterization Laboratories          
 8.5 Other End Users          
            
9 Global Peripheral Interventions Market, By Geography           
 9.1 Introduction          
 9.2 North America          
  9.2.1 US         
  9.2.2 Canada         
  9.2.3 Mexico         
 9.3 Europe          
  9.3.1 Germany         
  9.3.2 UK         
  9.3.3 Italy         
  9.3.4 France         
  9.3.5 Spain         
  9.3.6 Rest of Europe         
 9.4 Asia Pacific          
  9.4.1 Japan         
  9.4.2 China         
  9.4.3 India         
  9.4.4 Australia         
  9.4.5 New Zealand         
  9.4.6 South Korea         
  9.4.6 Rest of Asia Pacific         
 9.5 South America          
  9.5.1 Argentina         
  9.5.2 Brazil         
  9.5.3 Chile         
  9.5.4 Rest of South America         
 9.6 Middle East & Africa          
  9.6.1 Saudi Arabia         
  9.6.2 UAE         
  9.6.3 Qatar         
  9.6.4 South Africa         
  9.6.5 Rest of Middle East & Africa         
            
10 Key Developments           
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures          
 10.2 Acquisitions & Mergers          
 10.3 New Product Launch          
 10.4 Expansions          
 10.5 Other Key Strategies          
            
11 Company Profiling           
 11.1 Boston Scientific Corporation          
 11.2 Abbott Laboratories          
 11.3 W. L. Gore & Associates Inc          
 11.4 AngioDynamics Inc.          
 11.5 Medtronic          
 11.6 Teleflex Incorporated          
 11.6 Cardinal Health Inc          
 11.7 Terumo Corporation          
 11.8 Biotronik SE & Co. KG          
 11.9 C.R. Bard Inc.          
 11.10 Cook Medical          
 11.11 Terumo Interventional Systems Inc          
 11.12 Becton Dickinson and Company          
 11.13 B. Braun Melsungen AG          
 11.14 St. Jude Medical          
            
List of Tables            
1 Global Peripheral Interventions Market Outlook, By Region (2021-2030) ($MN)           
2 Global Peripheral Interventions Market Outlook, By Product (2021-2030) ($MN)           
3 Global Peripheral Interventions Market Outlook, By Catheters (2021-2030) ($MN)           
4 Global Peripheral Interventions Market Outlook, By Sheath (2021-2030) ($MN)           
5 Global Peripheral Interventions Market Outlook, By Guide Wires (2021-2030) ($MN)           
6 Global Peripheral Interventions Market Outlook, By Atherectomy Devices (2021-2030) ($MN)           
7 Global Peripheral Interventions Market Outlook, By Embolic Devices (2021-2030) ($MN)           
8 Global Peripheral Interventions Market Outlook, By Stents (2021-2030) ($MN)           
9 Global Peripheral Interventions Market Outlook, By Bare Metal Stents (2021-2030) ($MN)           
10 Global Peripheral Interventions Market Outlook, By Drug-Eluting Stents (2021-2030) ($MN)           
11 Global Peripheral Interventions Market Outlook, By Inferior Vena Cava (IVC) (2021-2030) ($MN)           
12 Global Peripheral Interventions Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)           
13 Global Peripheral Interventions Market Outlook, By Plaque Modification Device (2021-2030) ($MN)           
14 Global Peripheral Interventions Market Outlook, By Hemodynamic Flow Alteration Devices (2021-2030) ($MN)           
15 Global Peripheral Interventions Market Outlook, By Other Products (2021-2030) ($MN)           
16 Global Peripheral Interventions Market Outlook, By Procedures (2021-2030) ($MN)           
17 Global Peripheral Interventions Market Outlook, By Oncology Procedures (2021-2030) ($MN)           
18 Global Peripheral Interventions Market Outlook, By Gastric (2021-2030) ($MN)           
19 Global Peripheral Interventions Market Outlook, By Neurology (2021-2030) ($MN)           
20 Global Peripheral Interventions Market Outlook, By Skin Procedures (2021-2030) ($MN)           
21 Global Peripheral Interventions Market Outlook, By Uteral (2021-2030) ($MN)           
22 Global Peripheral Interventions Market Outlook, By Renal (2021-2030) ($MN)           
23 Global Peripheral Interventions Market Outlook, By Hepatic (2021-2030) ($MN)           
24 Global Peripheral Interventions Market Outlook, By Other Procedures (2021-2030) ($MN)           
25 Global Peripheral Interventions Market Outlook, By Application (2021-2030) ($MN)           
26 Global Peripheral Interventions Market Outlook, By Venous Thromboembolism (2021-2030) ($MN)           
27 Global Peripheral Interventions Market Outlook, By Peripheral Artery Disease (2021-2030) ($MN)           
28 Global Peripheral Interventions Market Outlook, By Other Applications (2021-2030) ($MN)           
29 Global Peripheral Interventions Market Outlook, By End User (2021-2030) ($MN)           
30 Global Peripheral Interventions Market Outlook, By Hospitals (2021-2030) ($MN)           
31 Global Peripheral Interventions Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)           
32 Global Peripheral Interventions Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)           
33 Global Peripheral Interventions Market Outlook, By Other End Users (2021-2030) ($MN)           
            
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials